Clinical trials
Glioblastoma trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Not yet recruiting | 7 |
| Recruiting | 6 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire, Amiens | 3 |
| Hospices Civils de Lyon | 3 |
| Institut Claudius Regaud | 3 |
| Centre Georges Francois Leclerc | 2 |
| Centre Leon Berard | 2 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Beta Emitting Accurate Monitored Systems | 1 |
| Boston Scientific Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 28 |
| Glioma | 3 |
| Brain Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Genetic Diseases, Inborn | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.